Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
Phosphodiesterases in neurodegenerative disorders.
Natalizumab in the treatment of pediatric multiple sclerosis.
Autonomic dysfunction in multiple sclerosis.
Quantifying progression of multiple sclerosis via classification of depth videos.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
A prospective cohort study of vitamin D in optic neuritis recovery.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Tetracyclines and neuromuscular disorders.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.
Pages
« first
‹ previous
…
347
348
349
350
351
352
353
354
355
…
next ›
last »